EUVIMEDEUVIMED entdecken
Crossref

Professor & Head, Department of Anatomy, Integral Institute of Medical Sciences and Research, Lucknow, UP, India

Annu Malik, Anima Prasad, Namrata Sinha, Shalini Mishra

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.96 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Annu Malik und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postpartum haemorrhage (PPH) remains a leading cause of maternal mortality, predominantly due to uterine atony. Oxytocin is the standard prophylactic uterotonic; however, its short duration of action and requirement for cold chain storage limit its effectiveness in certain settings. Carbetocin, a long-acting and heatstable oxytocin analogue, offers the advantage of sustained uterine contraction. This study aimed to compare the effectiveness of carbetocin and oxytocin in the prevention of PPH at a tertiary care centre.

Methods

Prospective comparative study was conducted at T.S. Misra Medical College and Hospital, Lucknow, from July 2024 to December 2025. A total of 100 pregnant women aged 18–40 years were included and equally allocated into two groups: carbetocin (100 µg intravenous bolus) and oxytocin (10 IU intramuscular), administered at delivery of the anterior shoulder. Blood loss was assessed using both objective and visual methods. The primary outcome was the incidence of PPH (>500 mL after vaginal delivery or >1000 mL after caesarean section within 24 hours). Secondary outcomes included total blood loss, changes in haemoglobin and haematocrit levels, need for additional uterotonics, uterine tone, requirement of blood transfusion, and adverse effects. Statistical analysis was performed using appropriate tests, with p < 0.05 considered significant.

Results

Baseline demographic and clinical characteristics were comparable between the two groups (p > 0.05). The incidence of PPH was lower in the carbetocin group (2%) compared to the oxytocin group (10%), although the difference was not statistically significant (p = 0.092). Atonic PPH was the most common type observed. In vaginal deliveries, blood loss >500 mL was significantly lower in the carbetocin group (0% vs. 4%; p = 0.030). Mean blood loss and the decline in haemoglobin and haematocrit levels were comparable between groups. A significantly higher proportion of women in the carbetocin group had a firm uterus at 15 minutes postpartum (92% vs. 78%; p = 0.049). The need for blood transfusion (6% vs. 18%) and additional uterotonics was higher in the oxytocin group, although these differences were not statistically significant.

Conclusion

Carbetocin is a safe and effective alternative to oxytocin for the prevention of postpartum haemorrhage. It demonstrates superior early uterine tone and favourable clinical trends in reducing PPH incidence and intervention requirements. Carbetocin may be particularly advantageous in resource-limited settings due to its prolonged action and heat stability.

Zitieren

APA

Malik, A., Prasad, A., Sinha, N., & Mishra, S. (2026). Professor & Head, Department of Anatomy, Integral Institute of Medical Sciences and Research, Lucknow, UP, India. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.96

Vancouver

Malik A, Prasad A, Sinha N, Mishra S. Professor & Head, Department of Anatomy, Integral Institute of Medical Sciences and Research, Lucknow, UP, India. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.96

BibTeX
@article{Malik2026,
  author = {Malik, Annu and Prasad, Anima and Sinha, Namrata and Mishra, Shalini},
  title = {Professor & Head, Department of Anatomy, Integral Institute of Medical Sciences and Research, Lucknow, UP, India},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.96}
}
Kostenlos starten →